Presenter: G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D
In episode 539, James and Mike focus in a PREMIUM way on the latest prostate cancer intervention trial. Patients with prostate cancer were randomized to active monitoring, surgery, or radiotherapy and followed for 15 years to see which was the best option. Have a listen and hear what was found. Show Notes 1) Fifteen-Year Outcomes…
This content is for *CFPC Member Rate, CFPC Member Rate, Non-CFPC Member Rate, and Resident members only.
Login Join Now
Login Join Now
Latest Podcasts
BS Medicine Episode 551: Statins in older adults – there is an answer!
In episode 551, James and Mike invite Danielle Perry back to the podcast to talk about the best available evidence for the use of statins in people 65 and over.…
BS Medicine Episode 550: PREMIUM – Lipids and bempedoic acid – to be right look at what is left
In episode 550, James and Mike talk in a PREMIUM way about a new cholesterol lowering agent. Bempedoic acid is nothing tremendously exciting but what was very interesting was a…
BS Medicine Episode 549: Triglyce-Ride That High?
In episode 549, James and Mike invite Blair MacDonald to the podcast for the first time and we talk about a topic that we haven’t really covered to-date. We discuss…
June 7, 2023
Presenter(s):
G. Michael Allan MD CCFP James McCormack BSc (Pharm) Pharm D
Please provide any additional comments (optional).